Zum Hauptinhalt springen

[Can breast cancer be prevented?].

Vatten, LJ
In: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, Jg. 111 (1991-05-30), Heft 14, S. 1745-8
academicJournal

Titel:
[Can breast cancer be prevented?].
Autor/in / Beteiligte Person: Vatten, LJ
Zeitschrift: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, Jg. 111 (1991-05-30), Heft 14, S. 1745-8
Veröffentlichung: Oslo : Norske Laegeforening ; <i>Original Publication</i>: Chistiania : Alb. Cammermeyer, 1880-, 1991
Medientyp: academicJournal
ISSN: 0029-2001 (print)
Schlagwort:
  • Adolescent
  • Adult
  • Alcohol Drinking adverse effects
  • Contraceptives, Oral adverse effects
  • Feeding Behavior
  • Female
  • Humans
  • Middle Aged
  • Obesity complications
  • Primary Prevention
  • Reproduction
  • Risk Factors
  • Breast Neoplasms prevention & control
Sonstiges:
  • Nachgewiesen in: MEDLINE
  • Sprachen: Norwegian
  • Transliterated Title: Kan brystkreft forebygges?
  • Publication Type: Journal Article; Review
  • Language: Norwegian
  • [Tidsskr Nor Laegeforen] 1991 May 30; Vol. 111 (14), pp. 1745-8.
  • MeSH Terms: Breast Neoplasms / *prevention & control ; Adolescent ; Adult ; Alcohol Drinking / adverse effects ; Contraceptives, Oral / adverse effects ; Feeding Behavior ; Female ; Humans ; Middle Aged ; Obesity / complications ; Primary Prevention ; Reproduction ; Risk Factors
  • Number of References: 25
  • Contributed Indexing: Indexing Agency: PIP Local ID #: 068358. Indexing Agency: POP Local ID #: 00224233. ; Keywords: Age Factors--women*; Alcohol Drinking*; Americas; Behavior; Biology; Body Weight--women*; Breast Cancer*; California; Cancer; Contraception; Contraceptive Methods--side effects; Cultural Background; Demographic Factors; Developed Countries; Diet--women*; Diseases; Endocrine System; Estrogens*; Ethnic Groups*; Europe; Family Planning; Fertility Agents; Health; Hormones; Incidence*; Lipids*; Longterm Effects*; Measurement; Menarche*; Menopause*; Menstruation; Migrants--women*; Migration; Neoplasms; North America; Northern America; Northern Europe; Norway; Nutrition; Oral Contraceptives--side effects*; Physiology; Population; Population Characteristics; Population Dynamics; Progestational Hormones*; Reproduction; Reproductive Control Agents; Research Methodology; Risk Factors*; Scandinavia; Tamoxifen*; Time Factors; United States; World* ; Note: TJ: TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING. ; Local Abstract: [PIP] In 1980, there were 570,000 cases of breast cancer in the world. In Norway, there are an average of 2000 new cases per year, and incidence had increased 50% from 1955 to 1984. About 40% of those afflicted die of the disease. Environmental, age, and reproductive factors seem to be implicated in its genesis. The rate increased almost fivefold in the course of a generation among Polish people who migrated to California from low incidence areas. It doubled among Chinese and Japanese who moved to California. The rate increases sharply up to age 50, then it levels off, thus early menopause is protective. Ovarial hormones (estrogen and progesterone) play a role in the development of preclinical tumors. Younger age at first delivery offers protection, but women who give birth to their first child after age 35 face a higher risk than nulliparas. Women with early menarche, which can be delayed by a lower caloric intake and vigorous physical activity, also face a heightened risk. Before menopause, overweight women are relatively protected, but the reverse is true after age 60. The consumption of animal fat is another risk factor, although a US study that involved 90,000 nurses did not bear this out. The Japanese increased their intake of animal fat from 10-25% from 1955-1975 without a corresponding increase in the rate of breast cancer. A vegetarian diet is nonprotective. Even the moderate consumption of alcohol increases the risk by 40% for women aged 15-30. Long-term use of oral contraceptives before birth of the first child up to age 35 increases the risk. Tamoxifen has protected women with a familial history of breast cancer who face a 3-5 fold higher risk. After menopause, its estrogenic properties promote the risk. Tamoxifen has an antitumor effect that can treat tumors clinically which are not manifested; it also lowers LDL (low density lipoprotein) and increases HDL (high density lipoprotein) cholesterol.
  • Substance Nomenclature: 0 (Contraceptives, Oral)
  • Entry Date(s): Date Created: 19910530 Date Completed: 19910806 Latest Revision: 20161123
  • Update Code: 20231215

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

oder
oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

oder
oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

xs 0 - 576
sm 576 - 768
md 768 - 992
lg 992 - 1200
xl 1200 - 1366
xxl 1366 -